LINAC

TTG Imaging Solutions Announces Acquisition of Acceletronics and RadParts

Retrieved on: 
Friday, October 7, 2022
ISO, Efficiency, Cardiology, ISO 9001:2015, Solution, Organization, LLC, MI, OEM, LINAC, TTG, Multimedia, Particle accelerator, American City Business Journals, Isotope, Acquisition, Radiation therapy, CEO, American, Pharmacy, View, Medical imaging, Management

PITTSBURGH, Oct. 7, 2022 /PRNewswire/ -- TTG Imaging Solutions, LLC (TTG) announced today the acquisition of Acceletronics, headquartered in Exton, PA, and sister company RadParts, headquartered in Haslett, MI. The acquisition closed on August 26, 2022.

Key Points: 
  • PITTSBURGH, Oct. 7, 2022 /PRNewswire/ -- TTG Imaging Solutions, LLC (TTG)announced today the acquisition of Acceletronics, headquartered in Exton, PA, and sister company RadParts, headquartered in Haslett, MI.
  • Matt Mastarone, President & CEO of TTG said, "The acquisition of both Acceletronics and RadParts cements TTG as a full-service provider to the radiation oncology industry.
  • We began this journey into LINAC in Q1 of 2022 with the acquisition of Vanguard Solutions and I welcome the team members from Acceletronics and RadParts into the TTG family."
  • Larry Day, CEO of Acceletronics and RadParts, added, "This merger/acquisition with TTG creates tremendous opportunity for the employees of Acceletronics and RadParts.

Arizona Oncology Cancer Center working with NexCore Group on new cancer treatment center

Retrieved on: 
Thursday, October 6, 2022
Physician, Caregiver, HDR, Radiation oncologist, Healthcare Facilities Accreditation Program, Disease, Radiation, LINAC, Patient, Hospital, Hematology-Oncology and Stem Cell Transplantation Research Center, Urology, Modern Healthcare, Cancer, CT, Google Images, Radiation therapy, Real estate development, Breast cancer, Nutritionist, Oncology, Pharmacist, Surgical oncology, FDA, PET-CT, Medical imaging, Medicine, Hematology, Research, Medicine

DENVER, Oct. 6, 2022 /PRNewswire/ -- This past weekend, national health care, life sciences and senior housing real estate developer NexCore Group, in collaboration with Arizona Oncology, broke ground on a state-of-the-art cancer treatment center in Prescott, Ariz. located at 5430 Landmark Lane. Arizona Oncology, one of the largest medical groups in Arizona devoted exclusively to cancer care, and NexCore will develop a new 22,105-square-foot facility anticipated to open in September 2023. Once operational, the Arizona Oncology Cancer Center will offer patients in the region convenient access to the latest cancer treatment services and technologies.

Key Points: 
  • Once operational, the Arizona Oncology Cancer Center will offer patients in the region convenient access to the latest cancer treatment services and technologies.
  • The Arizona Oncology Cancer Center is currently located at 3188 N. Windsong Dr. but will relocate once this project is complete.
  • "Arizona Oncology is committed to evolving our practices to best fit the needs of our patients," said Iyad Hamarneh, medical oncologist with Arizona Oncology.
  • When completed, our cancer center will be the only practice in the quad-city region that will offer medical oncology, radiation oncology and hematology services for our community."

Global Radiotherapy Market Report 2022: Rising Cancer Prevalence Worldwide to Drive Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 17, 2022
Health, Oncology, Hospital, Radiation, Neoplasm, LDR, Growth, Cancer, Incidence, Radiation therapy, IGRT, HDR, IMRT, Awareness, Radiology, CAGR, Particle accelerator, LINAC, Particle therapy, Stereotactic surgery, Prostate, Oncology, Product, USD, Adoption, Medical imaging, Pharmaceutical industry, Breast, Technology

Technological advancements in radiotherapy and the rising incidence of cancer are the major factors driving the growth of this market.

Key Points: 
  • Technological advancements in radiotherapy and the rising incidence of cancer are the major factors driving the growth of this market.
  • Additionally, growing awareness of the benefits of radiotherapy and the increasing use of particle therapy for cancer treatment are other factors driving the growth of this market.
  • The service segment, by type, is expected to register the highest growth rate in the global radiotherapy market during the forecast period 2022-2027.
  • Based on technology, the radiotherapy market has been segmented into external beam radiotherapy and internal beam radiotherapy.

Karmanos Cancer Institute completes expansion of cancer network into Ohio

Retrieved on: 
Tuesday, April 12, 2022
Patient, CEO, Thought, Population, National Cancer Institute, Google Images, Research, Karmanos Cancer Institute, Education, Growth, MMM, Mortality, Technology, LINAC, History, Neoplasm, Disease, Multimedia, Partnership, NCI, Oncology, Cancer, Pharmaceutical industry, Karmanos

DETROIT, April 12, 2022 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute, headquartered in Detroit, has completed its expansion into Ohio with the opening of the Karmanos Cancer Institute at The Toledo Clinic Cancer Center in Maumee. This expansion marks the first time the world-renown cancer center will provide its level of National Cancer Institute-designated care outside of Michigan.

Key Points: 
  • DETROIT, April 12, 2022 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute, headquartered in Detroit, has completed its expansion into Ohio with the opening of the Karmanos Cancer Institute at The Toledo Clinic Cancer Center in Maumee.
  • This growth across state lines brings advanced cancer care to the patients of Northwest Ohio, which includes increased access to clinical trials and the expertise and experience of the Karmanos Cancer Network of oncologists and other cancer specialists.
  • "This expansion into Northwest Ohio is a great achievement for our Institute, but the best part is how it will benefit the communities of the region," said Gerold Bepler, M.D., Ph.D., president and CEO of Karmanos Cancer Institute.
  • The National Cancer Institute recognizes Karmanos as one of the best cancer centers in the nation with a comprehensive cancer center designation.

Global Radiation Therapy in the Oncology Market (2021 to 2031) - Featuring Accuray, Elekta and General Electric Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, August 9, 2021
Radiology, Health, Oncology, Zap, CAGR, Diagnosis, Siemens, ICAD Inc., Hitachi, Cancer, Synchrocyclotron, HDR, Radiation, Industry, Proton, Growth, Patient, Varian Medical Systems, Synchrotron, Oncology, Safety, Photon, LINAC, General Electric Company, Cyclotron, Medical imaging, Pharmaceutical industry

Radiation therapy in the oncology market is a treatment method to treat any type of cancer/tumor with the help of radiation.

Key Points: 
  • Radiation therapy in the oncology market is a treatment method to treat any type of cancer/tumor with the help of radiation.
  • The term 'radiation therapy' mostly refers to external beam radiation therapy, but it also means internal beam radiation therapy too.
  • What are the major market drivers, challenges, and opportunities in the global radiation therapy in oncology market?
  • What was the market value of the leading segments of the global radiation therapy in oncology market in 2020?